Finance and markets: business, quotes, gold, energy and releases.
Found 50371 articles
A securities class action lawsuit filed against DICK'S Sporting Goods, Inc. alleges the retailer misled shareholders regarding the financial health of its Foot Locker business. The complaint claims management downplayed promotional pressures and inventory vulnerabilities for months before a sharp August 2026 stock decline wiped out significant market value.
A securities class action has been filed against Better Home & Finance Holding Company, alleging the firm misled investors by reaffirming aggressive loan volume targets despite an internal slowdown. The litigation focuses on a period between March and May 2026, when shares plummeted following the sudden deferral of key growth goals.
The Defense Industrial Base continues to prioritize cybersecurity investment even as the Department of Defense pauses Phase 2 of the CMMC rollout. While some contractors have used the November 2026 scheduling shift as a reason to slow certification efforts, the majority report steady progress toward independent validation and compliance.
A securities class action lawsuit has been filed against FuelCell Energy, Inc. following allegations that the company misled investors regarding its manufacturing capacity and ability to meet contractual obligations. The litigation centers on a 380-megawatt deal that reportedly failed to account for significant production shortfalls and subsequent financial charges.
A 7.22% intraday drop in Neogen Corporation shares has triggered a securities investigation by the firm Levi & Korsinsky. The selloff followed federal warnings regarding the company's equine product HYCOAT, which regulators identified as carrying multiple fungal species despite being marketed as a sterile veterinary solution.
A securities class action lawsuit alleges that Unicycive Therapeutics misled investors by failing to verify a contract manufacturer's compliance status before resubmitting an application for its drug, oxylanthanum carbonate. The oversight led to a second FDA rejection and a 39.1% single-day collapse in the company's share price.
Investors who purchased Lincoln Educational Services stock between May 11 and August 9, 2026, are now eligible to join a securities class action. The lawsuit alleges the company misled shareholders by inflating growth forecasts while failing to disclose that enrolled students were failing to attend classes.
Investors in Endava plc are facing a November 30, 2026, deadline to seek lead plaintiff status in a class action lawsuit targeting the company’s leadership. The complaint centers on allegations that CEO John Cotterell and CFO Mark Thurston provided misleading certifications regarding internal financial controls.
Investors who purchased Ardelyx, Inc. securities between January 13, 2025, and August 6, 2026, have until November 16, 2026, to seek lead plaintiff status in a pending class action lawsuit. The litigation centers on claims that the company misled shareholders regarding the growth prospects of its flagship drugs.
Investors who purchased Ryde Group Ltd shares between March 6 and September 11, 2024, are facing a November 9, 2026, deadline to serve as lead plaintiff in a class action lawsuit. The litigation follows a dramatic stock collapse that saw shares plummet from a peak of $22.49 to near $0.50.
Institutional investors and fiduciaries holding Doximity, Inc. stock must decide by November 16, 2026, whether to seek a lead plaintiff role in a class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s revenue growth and competitive standing during a period marked by sharp share price volatility.
Fair Isaac Corporation shares plummeted over 20% following a Federal Housing Finance Agency decision to overhaul mortgage pricing grids. The sharp market reaction has triggered an investigation by litigation firm Levi & Korsinsky into whether company leadership misled shareholders regarding the competitive and regulatory risks facing its core mortgage scoring business.
A securities class action lawsuit filed against Beta Bionics, Inc. alleges the medical device company misled shareholders by promoting the iLet insulin pump's clinical success while concealing a June 2025 FDA report that documented more than 18,000 unreported customer complaints regarding the device's safety and performance.
Families often struggle with rigid mobile-only healthcare requirements, but Pacify is shifting its strategy to ensure broader reach. The company’s new web-based portal allows parents to access lactation consultants and certified doulas directly through browsers, bypassing the technological hurdles of smartphone dependency and limited data plans.
With over 900 locations nationwide, the infrared fitness franchise HOTWORX has officially kicked off its annual Workouts for Heroes campaign. Running through November 30, the initiative directs all proceeds to the National Breast Cancer Foundation’s Military Women’s Patient Relief Fund to assist with non-medical expenses during cancer treatment.
On December 3, 2026, London’s King's Cross will host a gathering of R&D leaders tasked with navigating the intersection of artificial intelligence and clinical validation. Held at The Mills Fabrica, the Sequential-led forum marks a shift in how the beauty and biotechnology sectors verify the efficacy of next-generation ingredients.
As world leaders and diplomats converge in New York for the United Nations General Assembly, Bond No. 9 is marking the occasion with a new fragrance. The Scent of Peace for All serves as an olfactory tribute to global cooperation, aiming to capture the shared human desire for harmony.
For many emerging franchisors, the leap to a full-scale national sales team is a bridge too far. Omaha-based Franchise FastLane is now addressing this gap with a new fractional service, allowing brands to access professional development directors on a part-time basis rather than committing to costly in-house overhead.
Investors who held Blaize Holdings, Inc. stock between July 17, 2025, and August 13, 2026, have until October 5, 2026, to seek lead plaintiff status in a federal securities class action. The lawsuit follows allegations that the company inflated its financial performance through questionable transactions with undercapitalized entities.
A securities class action lawsuit has been filed against PROCEPT BioRobotics, alleging the company misled investors by artificially inflating sales figures. The complaint, initiated by a shareholder on July 24, 2026, claims the firm utilized undisclosed discount programs to drive bulk orders that far exceeded actual market demand.
Artificial intelligence and multi-omics are dismantling traditional product development cycles, forcing a shift in how the beauty and biotech industries validate new molecules. On December 3, 2026, industry leaders will gather at The Mills Fabrica in London to address these emerging demands for scientific transparency and clinical proof.
Santa Claus may be famous for his love of cookies, but North American seafood brand Just Shrimp is betting he prefers a crispy, protein-rich snack. The company has officially designated October 25 as Shrimpmas, a new holiday falling exactly two months before Christmas to celebrate the versatility of coastal shrimp.
Ashburn-based infrastructure firm CPG has appointed industry veteran Russ Morrissey as President, effective October 1, 2026. Reporting directly to CEO Keith Lambert, Morrissey will oversee daily operations and strategic execution as the company targets further expansion across the data center and mission-critical facility sectors.
One in five American adults suffers from chronic pain, a condition often exacerbated by isolation. A study published in the Annals of Family Medicine suggests that structured group medical visits provide a scalable, biopsychosocial solution by fostering four distinct forms of social support among patients in primary care settings.
Australian-born photographer Peter Lik has planted a new creative flag in Manhattan, opening a permanent LIK Fine Art gallery at 689 Fifth Avenue. Situated within the historic, landmarked Aeolian Building near Rockefeller Center, the space serves as a dedicated showcase for the artist’s expansive, large-format landscape and cityscape photography.
Investors who held ARS Pharmaceuticals shares between March 9 and June 24, 2026, face an October 5 deadline to file for lead plaintiff status in a federal class action. The litigation centers on allegations that the company misled shareholders regarding the timeline for neffy insurance coverage through CVS Caremark.
Imbed Biosciences has officially registered its FDA-approved safety study for the DualGuard™ Silver-Gallium Matrix on ClinicalTrials.gov. The trial, designated NCT07695688, evaluates the investigational product on split-thickness skin graft donor sites across three American Burn Association-verified centers, marking a significant step in the company’s efforts to combat biofilm-related infections.
After tripling its revenue in just 18 months, New York-based RK Partners has appointed veteran tax advisor Andrew Sams as its new Chief Executive Officer. Sams takes the helm as the consultancy looks to scale its operations while maintaining the boutique, high-touch service that helped secure $130 million in tax credits for clients.
Plano-based Zhone Technologies finalized its acquisition of Tellabs Access, LLC, a move designed to consolidate two major players in the fiber access and Optical LAN sectors. While the financial terms remain undisclosed, the deal integrates Tellabs’ extensive federal and enterprise customer base into Zhone’s existing global networking infrastructure operations.
Plano-based Zhone Technologies has completed the acquisition of Tellabs Access, LLC, a move aimed at consolidating fiber access and Optical LAN capabilities across North America. The deal merges two long-standing telecommunications players to target growth in the enterprise, government, and mission-critical networking sectors.